Alpha 2.0
Login Register
» Articles » PMID: 11387238

Lack of P53 Accelerates Hepatocarcinogenesis in Transgenic Mice Constitutively Overexpressing C-myc in the Liver

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2001 Jun 2
PMID 11387238
Citations 7
Authors
R Klocke
T Bartels
G Jennings
K Brand
R Halter
M Strauss
D Paul
Affiliations
Soon will be listed here.
Citing Articles

Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors.

Jiang Z, Cheng L, Wu Z, Zhou L, Wang H, Hong Q EMBO Rep. 2022; 23(6):e54275.

PMID: 35437924 PMC: 9171684. DOI: 10.15252/embr.202154275.

Oncogenic driver genes and tumor microenvironment determine the type of liver cancer.

Wang G, Wang Q, Liang N, Xue H, Yang T, Chen X Cell Death Dis. 2020; 11(5):313.

PMID: 32366840 PMC: 7198508. DOI: 10.1038/s41419-020-2509-x.

c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease.

Zheng K, Cubero F, Nevzorova Y Genes (Basel). 2017; 8(4).

PMID: 28422055 PMC: 5406870. DOI: 10.3390/genes8040123.

Cancer gene discovery in hepatocellular carcinoma.

Zender L, Villanueva A, Tovar V, Sia D, Chiang D, Llovet J J Hepatol. 2010; 52(6):921-9.

PMID: 20385424 PMC: 2905725. DOI: 10.1016/j.jhep.2009.12.034.

Deleted in liver cancer 2 (DLC2) was dispensable for development and its deficiency did not aggravate hepatocarcinogenesis.

Yau T, Leung T, Lam S, Cheung O, Tung E, Khong P PLoS One. 2009; 4(8):e6566.

PMID: 19668331 PMC: 2718616. DOI: 10.1371/journal.pone.0006566.